Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Tafuri

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
The Journal of Urology|April 5, 2021
Systematic Biopsy of the Prostate can Be Omitted in Men with PI-RADS™ 5 and Prostate Specific Antigen Density Greater than 15Alessandro Tafuri, Atsuko Iwata, Aliasger Shakir, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
Clinical Genitourinary Cancer|June 26, 2023
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder CancerAndrea Panunzio, Alessandra Gozzo, Giovanni Mazzucato, et al.
Urologia|May 23, 2019
Multiple stones in neobladder: Case report and literature reviewAlessandro Tafuri, Antonio B Porcaro, Akbar N Ashrafi, et al.
Cancers|June 19, 2024
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral CenterAntonio Benito Porcaro, Alberto Bianchi, Sebastian Gallina, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 14, 2024
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2bAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
Indian Journal of Surgical Oncology|January 23, 2023
American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer PatientsAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Journal of Robotic Surgery|June 16, 2021
Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomyAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
International Urology and Nephrology|July 2, 2020
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissectionAlessandro Tafuri, Nelia Amigoni, Riccardo Rizzetto, et al.
Journal of Robotic Surgery|March 23, 2024
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factorsAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
The Journal of Urology|April 5, 2021
Systematic Biopsy of the Prostate can Be Omitted in Men with PI-RADS™ 5 and Prostate Specific Antigen Density Greater than 15Alessandro Tafuri, Atsuko Iwata, Aliasger Shakir, et al.
International Urology and Nephrology|October 22, 2021
Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancerAntonio Benito Porcaro, Sebastian Gallina, Alberto Bianchi, et al.
Clinical Genitourinary Cancer|June 26, 2023
Impairment in Activities of Daily Living Assessed by the Barthel Index Predicts Adverse Oncological Outcomes After Radical Cystectomy for Bladder CancerAndrea Panunzio, Alessandra Gozzo, Giovanni Mazzucato, et al.
Urologia|May 23, 2019
Multiple stones in neobladder: Case report and literature reviewAlessandro Tafuri, Antonio B Porcaro, Akbar N Ashrafi, et al.
Cancers|June 19, 2024
Prognostic Impact and Clinical Implications of Adverse Tumor Grade in Very Favorable Low- and Intermediate-Risk Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy: Experience of a Single Tertiary Referral CenterAntonio Benito Porcaro, Alberto Bianchi, Sebastian Gallina, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 14, 2024
The 2012 Briganti nomogram not only predicts lymph node involvement but also disease progression in surgically treated intermediate-risk prostate cancer patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2bAntonio Benito Porcaro, Andrea Panunzio, Rossella Orlando, et al.
Indian Journal of Surgical Oncology|January 23, 2023
American Society of Anesthesiologists' (ASA) Physical Status System and Risk of Major Clavien-Dindo Complications After Robot-Assisted Radical Prostatectomy at Hospital Discharge: Analysis of 1143 Consecutive Prostate Cancer PatientsAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
Journal of Robotic Surgery|June 16, 2021
Severe intraoperative bleeding predicts the risk of perioperative blood transfusion after robot-assisted radical prostatectomyAntonio Benito Porcaro, Riccardo Rizzetto, Nelia Amigoni, et al.
International Urology and Nephrology|July 2, 2020
Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissectionAlessandro Tafuri, Nelia Amigoni, Riccardo Rizzetto, et al.
Journal of Robotic Surgery|March 23, 2024
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factorsAntonio Benito Porcaro, Rossella Orlando, Andrea Panunzio, et al.
Pageof 19